Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-27

Clinical Trial Update: Molecular Profile-related Individualized Targeted Therapy in Resected Pancreatic Cancer With High-Risk of Cancer Recurrence [NA]

View source ↗

Summary

This clinical trial assesses molecular profile-driven, individualized targeted therapy for patients with resected pancreatic cancer at high risk of recurrence; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Pancreas Cancer | NA | Status: RECRUITING